Elan Pharmaceuticals, Inc.
Records under this name other than the patents Elan Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Elan Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,697,082 | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,233,245 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,292,845 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,333,670 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,493,567 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,625,560 | Humanized Antibodies That Recognize Beta Amyloid Peptide Formerly held In force · High confidence | In force | High confidence | |
| US 7,576,101 | Composition for and Treatment of Demyelinating Diseases and Paralysis by Administration of Remyelinating Agents Formerly held In force · High confidence | In force | High confidence | |
| US 8,124,350 | Methods and Products for Evaluating an Immune Response to a Therapeutic Protein Formerly held In force · High confidence | In force | High confidence | |
| US 7,674,599 | Methods of Using Antibodies to Detect Alpha-Synuclein in Fluid Samples Formerly held In force · High confidence | In force | High confidence | |
| US 9,034,337 | Treatment and Delay of Outset of Synucleinopathic and Amyloidogenic Disease Formerly held In force · Medium confidence | In force | Medium confidence |